In the last six months, TransMedics Group Inc (NASDAQ: TMDX ) stock has fallen more than 50% from its ATH in 2024 due to missing expectations in both earnings and revenue amid Hi! I'm a passionate investor who has been researching publically traded companies for over 6 years. My primary focus is on identifying great businesses at reasonable prices and holding them for the long term. While I have a slight bias toward technology companies, I maintain a broad perspective, including opportunities in crypto. I t ...